The HPA Axis as Target for Depression

Ebmeier, K.P.; Donaghey, C.; Steele, J.D. Recent developments and current controversies in depression. Lancet, 2006, 367(9505), 153-167.
[http://dx.doi.org/10.1016/S0140-6736(06)67964-6] [PMID: 16413879]

Vos, T.; Barber, R.M.; Bell, B.; Bertozzi-Villa, A.; Biryukov, S.; Bolliger, I.; Charlson, F.; Davis, A.; Degenhardt, L.; Dicker, D.; Duan, L.; Erskine, H.; Feigin, V.L.; Ferrari, A.J.; Fitzmaurice, C.; Fleming, T.; Graetz, N.; Guinovart, C.; Haagsma, J.; Hansen, G.M.; Hanson, S.W.; Heuton, K.R.; Higashi, H.; Kassebaum, N.; Kyu, H.; Laurie, E.; Liang, X.; Lofgren, K.; Lozano, R.; MacIntyre, M.F.; Moradi-Lakeh, M.; Naghavi, M.; Nguyen, G.; Odell, S.; Ortblad, K.; Roberts, D.A.; Roth, G.A.; Sandar, L.; Serina, P.T.; Stanaway, J.D.; Steiner, C.; Thomas, B.; Vollset, S.E.; Whiteford, H.; Wolock, T.M.; Ye, P.; Zhou, M.; Ãvila, M.A.; Aasvang, G.M.; Abbafati, C.; Ozgoren, A.A.; Abd-Allah, F.; Aziz, M.I.A.; Abera, S.F.; Aboyans, V.; Abraham, J.P.; Abraham, B.; Abubakar, I.; Abu-Raddad, L.J.; Abu-Rmeileh, N.M.E.; Aburto, T.C.; Achoki, T.; Ackerman, I.N.; Adelekan, A.; Ademi, Z.; Adou, A.K.; Adsuar, J.C.; Arnlov, J.; Agardh, E.E.; Al Khabouri, M.J.; Alam, S.S.; Alasfoor, D.; Albittar, M.I.; Alegretti, M.A.; Aleman, A.V.; Alemu, Z.A.; Alfonso-Cristancho, R.; Alhabib, S.; Ali, R.; Alla, F.; Allebeck, P.; Allen, P.J.; AlMazroa, M.A.A.; Alsharif, U.; Alvarez, E.; Alvis-Guzman, N.; Ameli, O.; Amini, H.; Ammar, W.; Anderson, B.O.; Anderson, H.R.; Antonio, C.A.T.; Anwari, P.; Apfel, H.; Arsenijevic, V.S.A.; Artaman, A.; Asghar, R.J.; Assadi, R.; Atkins, L.S.; Atkinson, C.; Badawi, A.; Bahit, M.C.; Bakfalouni, T.; Balakrishnan, K.; Balalla, S.; Banerjee, A.; Barker-Collo, S.L.; Barquera, S.; Barregard, L.; Barrero, L.H.; Basu, S.; Basu, A.; Baxter, A.; Beardsley, J.; Bedi, N.; Beghi, E.; Bekele, T.; Bell, M.L.; Benjet, C.; Bennett, D.A.; Bensenor, I.M.; Benzian, H.; Bernabe, E.; Beyene, T.J.; Bhala, N.; Bhalla, A.; Bhutta, Z.; Bienhoff, K.; Bikbov, B.; Abdulhak, A.B.; Blore, J.D.; Blyth, F.M.; Bohensky, M.A.; Basara, B.B.; Borges, G.; Bornstein, N.M.; Bose, D.; Boufous, S.; Bourne, R.R.; Boyers, L.N.; Brainin, M.; Brauer, M.; Brayne, C.E.G.; Brazinova, A.; Breitborde, N.J.K.; Brenner, H.; Briggs, A.D.M.; Brooks, P.M.; Brown, J.; Brugha, T.S.; Buchbinder, R.; Buckle, G.C.; Bukhman, G.; Bulloch, A.G.; Burch, M.; Burnett, R.; Cardenas, R.; Cabral, N.L.; Nonato, I.R.C.; Campuzano, J.C.; Carapetis, J.R.; Carpenter, D.O.; Caso, V.; Castaneda-Orjuela, C.A.; Catala-Lopez, F.; Chadha, V.K.; Chang, J-C.; Chen, H.; Chen, W.; Chiang, P.P.; Chimed-Ochir, O.; Chowdhury, R.; Christensen, H.; Christophi, C.A.; Chugh, S.S.; Cirillo, M.; Coggeshall, M.; Cohen, A.; Colistro, V.; Colquhoun, S.M.; Contreras, A.G.; Cooper, L.T.; Cooper, C.; Cooperrider, K.; Coresh, J.; Cortinovis, M.; Criqui, M.H.; Crump, J.A.; Cuevas-Nasu, L.; Dandona, R.; Dandona, L.; Dansereau, E.; Dantes, H.G.; Dargan, P.I.; Davey, G.; Davitoiu, D.V.; Dayama, A.; De la Cruz-Gongora, V.; de la Vega, S.F.; De Leo, D.; del Pozo-Cruz, B.; Dellavalle, R.P.; Deribe, K.; Derrett, S.; Des Jarlais, D.C.; Dessalegn, M.; deVeber, G.A.; Dharmaratne, S.D.; Diaz-Torne, C.; Ding, E.L.; Dokova, K.; Dorsey, E.R.; Driscoll, T.R.; Duber, H.; Durrani, A.M.; Edmond, K.M.; Ellenbogen, R.G.; Endres, M.; Ermakov, S.P.; Eshrati, B.; Esteghamati, A.; Estep, K.; Fahimi, S.; Farzadfar, F.; Fay, D.F.J.; Felson, D.T.; Fereshtehnejad, S-M.; Fernandes, J.G.; Ferri, C.P.; Flaxman, A.; Foigt, N.; Foreman, K.J.; Fowkes, F.G.R.; Franklin, R.C.; Furst, T.; Futran, N.D.; Gabbe, B.J.; Gankpe, F.G.; Garcia-Guerra, F.A.; Geleijnse, J.M.; Gessner, B.D.; Gibney, K.B.; Gillum, R.F.; Ginawi, I.A.; Giroud, M.; Giussani, G.; Goenka, S.; Goginashvili, K.; Gona, P.; de Cosio, T.G.; Gosselin, R.A.; Gotay, C.C.; Goto, A.; Gouda, H.N.; Guerrant, R.; Gugnani, H.C.; Gunnell, D.; Gupta, R.; Gupta, R.; Gutierrez, R.A.; Hafezi-Nejad, N.; Hagan, H.; Halasa, Y.; Hamadeh, R.R.; Hamavid, H.; Hammami, M.; Hankey, G.J.; Hao, Y.; Harb, H.L.; Haro, J.M.; Havmoeller, R.; Hay, R.J.; Hay, S.; Hedayati, M.T.; Pi, I.B.H.; Heydarpour, P.; Hijar, M.; Hoek, H.W.; Hoffman, H.J.; Hornberger, J.C.; Hosgood, H.D.; Hossain, M.; Hotez, P.J.; Hoy, D.G.; Hsairi, M.; Hu, H.; Hu, G.; Huang, J.J.; Huang, C.; Huiart, L.; Husseini, A.; Iannarone, M.; Iburg, K.M.; Innos, K.; Inoue, M.; Jacobsen, K.H.; Jassal, S.K.; Jeemon, P.; Jensen, P.N.; Jha, V.; Jiang, G.; Jiang, Y.; Jonas, J.B.; Joseph, J.; Juel, K.; Kan, H.; Karch, A.; Karimkhani, C.; Karthikeyan, G.; Katz, R.; Kaul, A.; Kawakami, N.; Kazi, D.S.; Kemp, A.H.; Kengne, A.P.; Khader, Y.S.; Khalifa, S.E.A.H.; Khan, E.A.; Khan, G.; Khang, Y-H.; Khonelidze, I.; Kieling, C.; Kim, D.; Kim, S.; Kimokoti, R.W.; Kinfu, Y.; Kinge, J.M.; Kissela, B.M.; Kivipelto, M.; Knibbs, L.; Knudsen, A.K.; Kokubo, Y.; Kosen, S.; Kramer, A.; Kravchenko, M.; Krishnamurthi, R.V.; Krishnaswami, S.; Defo, B.K.; Bicer, B.K.; Kuipers, E.J.; Kulkarni, V.S.; Kumar, K.; Kumar, G.A.; Kwan, G.F.; Lai, T.; Lalloo, R.; Lam, H.; Lan, Q.; Lansingh, V.C.; Larson, H.; Larsson, A.; Lawrynowicz, A.E.B.; Leasher, J.L.; Lee, J-T.; Leigh, J.; Leung, R.; Levi, M.; Li, B.; Li, Y.; Li, Y. liang, J.; Lim, S.; Lin, H-H.; Lind, M.; Lindsay, M.P.; Lipshultz, S.E.; Liu, S.; Lloyd, B.K.; Ohno, S.L.; Logroscino, G.; Looker, K.J.; Lopez, A.D.; Lopez-Olmedo, N.; Lortet-Tieulent, J.; Lotufo, P.A.; Low, N.; Lucas, R.M.; Lunevicius, R.; Lyons, R.A.; Ma, J.; Ma, S.; Mackay, M.T.; Majdan, M.; Malekzadeh, R.; Mapoma, C.C.; Marcenes, W.; March, L.M.; Margono, C.; Marks, G.B.; Marzan, M.B.; Masci, J.R.; Mason-Jones, A.J.; Matzopoulos, R.G.; Mayosi, B.M.; Mazorodze, T.T.; McGill, N.W.; McGrath, J.J.; McKee, M.; McLain, A.; McMahon, B.J.; Meaney, P.A.; Mehndiratta, M.M.; Mejia-Rodriguez, F.; Mekonnen, W.; Melaku, Y.A.; Meltzer, M.; Memish, Z.A.; Mensah, G.; Meretoja, A.; Mhimbira, F.A.; Micha, R.; Miller, T.R.; Mills, E.J.; Mitchell, P.B.; Mock, C.N.; Moffitt, T.E.; Ibrahim, N.M.; Mohammad, K.A.; Mokdad, A.H.; Mola, G.L.; Monasta, L.; Montico, M.; Montine, T.J.; Moore, A.R.; Moran, A.E.; Morawska, L.; Mori, R.; Moschandreas, J.; Moturi, W.N.; Moyer, M.; Mozaffarian, D.; Mueller, U.O.; Mukaigawara, M.; Murdoch, M.E.; Murray, J.; Murthy, K.S.; Naghavi, P.; Nahas, Z.; Naheed, A.; Naidoo, K.S.; Naldi, L.; Nand, D.; Nangia, V.; Narayan, K.M.V.; Nash, D.; Nejjari, C.; Neupane, S.P.; Newman, L.M.; Newton, C.R.; Ng, M.; Ngalesoni, F.N.; Nhung, N.T.; Nisar, M.I.; Nolte, S.; Norheim, O.F.; Norman, R.E.; Norrving, B.; Nyakarahuka, L.; Oh, I.H.; Ohkubo, T.; Omer, S.B.; Opio, J.N.; Ortiz, A.; Pandian, J.D.; Panelo, C.I.A.; Papachristou, C.; Park, E-K.; Parry, C.D.; Caicedo, A.J.P.; Patten, S.B.; Paul, V.K.; Pavlin, B.I.; Pearce, N.; Pedraza, L.S.; Pellegrini, C.A.; Pereira, D.M.; Perez-Ruiz, F.P.; Perico, N.; Pervaiz, A.; Pesudovs, K.; Peterson, C.B.; Petzold, M.; Phillips, M.R.; Phillips, D.; Phillips, B.; Piel, F.B.; Plass, D.; Poenaru, D.; Polanczyk, G.V.; Polinder, S.; Pope, C.A.; Popova, S.; Poulton, R.G.; Pourmalek, F.; Prabhakaran, D.; Prasad, N.M.; Qato, D.; Quistberg, D.A.; Rafay, A.; Rahimi, K.; Rahimi-Movaghar, V.; Rahman, S.; Raju, M.; Rakovac, I.; Rana, S.M.; Razavi, H.; Refaat, A.; Rehm, J.; Remuzzi, G.; Resnikoff, S.; Ribeiro, A.L.; Riccio, P.M.; Richardson, L.; Richardus, J.H.; Riederer, A.M.; Robinson, M.; Roca, A.; Rodriguez, A.; Rojas-Rueda, D.; Ronfani, L.; Rothenbacher, D.; Roy, N.; Ruhago, G.M.; Sabin, N.; Sacco, R.L.; Ksoreide, K.; Saha, S.; Sahathevan, R.; Sahraian, M.A.; Sampson, U.; Sanabria, J.R.; Sanchez-Riera, L.; Santos, I.S.; Satpathy, M.; Saunders, J.E.; Sawhney, M.; Saylan, M.I.; Scarborough, P.; Schoettker, B.; Schneider, I.J.C.; Schwebel, D.C.; Scott, J.G.; Seedat, S.; Sepanlou, S.G.; Serdar, B.; Servan-Mori, E.E.; Shackelford, K.; Shaheen, A.; Shahraz, S.; Levy, T.S.; Shangguan, S.; She, J.; Sheikhbahaei, S.; Shepard, D.S.; Shi, P.; Shibuya, K.; Shinohara, Y.; Shiri, R.; Shishani, K.; Shiue, I.; Shrime, M.G.; Sigfusdottir, I.D.; Silberberg, D.H.; Simard, E.P.; Sindi, S.; Singh, J.A.; Singh, L.; Skirbekk, V.; Sliwa, K.; Soljak, M.; Soneji, S.; Soshnikov, S.S.; Speyer, P.; Sposato, L.A.; Sreeramareddy, C.T.; Stoeckl, H.; Stathopoulou, V.K.; Steckling, N.; Stein, M.B.; Stein, D.J.; Steiner, T.J.; Stewart, A.; Stork, E.; Stovner, L.J.; Stroumpoulis, K.; Sturua, L.; Sunguya, B.F.; Swaroop, M.; Sykes, B.L.; Tabb, K.M.; Takahashi, K.; Tan, F.; Tandon, N.; Tanne, D.; Tanner, M.; Tavakkoli, M.; Taylor, H.R.; Te Ao, B.J.; Temesgen, A.M.; Have, M.T.; Tenkorang, E.Y.; Terkawi, A.S.; Theadom, A.M.; Thomas, E.; Thorne-Lyman, A.L.; Thrift, A.G.; Tleyjeh, I.M.; Tonelli, M.; Topouzis, F.; Towbin, J.A.; Toyoshima, H.; Traebert, J.; Tran, B.X.; Trasande, L.; Trillini, M.; Truelsen, T.; Trujillo, U.; Tsilimbaris, M.; Tuzcu, E.M.; Ukwaja, K.N.; Undurraga, E.A.; Uzun, S.B.; van Brakel, W.H.; van de Vijver, S.; Dingenen, R.V.; van Gool, C.H.; Varakin, Y.Y.; Vasankari, T.J.; Vavilala, M.S.; Veerman, L.J.; Velasquez-Melendez, G.; Venketasubramanian, N.; Vijayakumar, L.; Villalpando, S.; Violante, F.S.; Vlassov, V.V.; Waller, S.; Wallin, M.T.; Wan, X.; Wang, L.; Wang, J.L.; Wang, Y.; Warouw, T.S.; Weichenthal, S.; Weiderpass, E.; Weintraub, R.G.; Werdecker, A.; Wessells, K.R.R.; Westerman, R.; Wilkinson, J.D.; Williams, H.C.; Williams, T.N.; Woldeyohannes, S.M.; Wolfe, C.D.A.; Wong, J.Q.; Wong, H.; Woolf, A.D.; Wright, J.L.; Wurtz, B.; Xu, G.; Yang, G.; Yano, Y.; Yenesew, M.A.; Yentur, G.K.; Yip, P.; Yonemoto, N.; Yoon, S-J.; Younis, M.; Yu, C.; Kim, K.Y.; Zaki, M.E.S.; Zhang, Y.; Zhao, Z.; Zhao, Y.; Zhu, J.; Zonies, D.; Zunt, J.R.; Salomon, J.A.; Murray, C.J.L. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 386(9995), 743-800.
[http://dx.doi.org/10.1016/S0140-6736(15)60692-4] [PMID: 26063472]

Monroe, S.M.; Harkness, K.L. Major depression and its recurrences: Life course matters. Annu. Rev. Clin. Psychol., 2022, 18(1), 329-357.
[http://dx.doi.org/10.1146/annurev-clinpsy-072220-021440] [PMID: 35216520]

Lépine, J.P.; Briley, M. The increasing burden of depression. Neuropsychiatr. Dis. Treat., 2011, 7(Suppl. 1), 3-7.
[PMID: 21750622]

Laursen, T.M.; Musliner, K.L.; Benros, M.E.; Vestergaard, M.; Munk-Olsen, T. Mortality and life expectancy in persons with severe unipolar depression. J. Affect. Disord., 2016, 193, 203-207.
[http://dx.doi.org/10.1016/j.jad.2015.12.067] [PMID: 26773921]

Chesney, E.; Goodwin, G.M.; Fazel, S. Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry, 2014, 13(2), 153-160.
[http://dx.doi.org/10.1002/wps.20128] [PMID: 24890068]

Penninx, B.W.J.H.; Milaneschi, Y.; Lamers, F.; Vogelzangs, N. Understanding the somatic consequences of depression: Biological mechanisms and the role of depression symptom profile. BMC Med., 2013, 11(1), 129.
[http://dx.doi.org/10.1186/1741-7015-11-129] [PMID: 23672628]

Ruhé, H.G.; Huyser, J.; Swinkels, J.A.; Schene, A.H. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: A systematic review. J. Clin. Psychiatry, 2006, 67(12), 1836-1855.
[http://dx.doi.org/10.4088/JCP.v67n1203] [PMID: 17194261]

Rush, A.J.; Trivedi, M.H.; Wisniewski, S.R.; Stewart, J.W.; Nierenberg, A.A.; Thase, M.E.; Ritz, L.; Biggs, M.M.; Warden, D.; Luther, J.F.; Shores-Wilson, K.; Niederehe, G.; Fava, M. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med., 2006, 354(12), 1231-1242.
[http://dx.doi.org/10.1056/NEJMoa052963] [PMID: 16554525]

Giakoumatos, C.I.; Osser, D. The psychopharmacology algorithm project at the harvard south shore program: An update on unipolar nonpsychotic depression. Harv. Rev. Psychiatry, 2019, 27(1), 33-52.
[http://dx.doi.org/10.1097/HRP.0000000000000197] [PMID: 30614886]

Otte, C.; Gold, S.M.; Penninx, B.W.; Pariante, C.M.; Etkin, A.; Fava, M.; Mohr, D.C.; Schatzberg, A.F. Major depressive disorder. Nat. Rev. Dis. Primers, 2016, 2(1), 16065.
[http://dx.doi.org/10.1038/nrdp.2016.65] [PMID: 27629598]

Ormel, J.; Oldehinkel, A.J.; Nolen, W.A.; Vollebergh, W. Psychosocial disability before, during, and after a major depressive episode: A 3-wave population-based study of state, scar, and trait effects. Arch. Gen. Psychiatry, 2004, 61(4), 387-392.
[http://dx.doi.org/10.1001/archpsyc.61.4.387] [PMID: 15066897]

Wittchen, H.U.; Jacobi, F.; Rehm, J.; Gustavsson, A.; Svensson, M.; Jönsson, B.; Olesen, J.; Allgulander, C.; Alonso, J.; Faravelli, C.; Fratiglioni, L.; Jennum, P.; Lieb, R.; Maercker, A.; van Os, J.; Preisig, M.; Salvador-Carulla, L.; Simon, R.; Steinhausen, H.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol., 2011, 21(9), 655-679.
[http://dx.doi.org/10.1016/j.euroneuro.2011.07.018] [PMID: 21896369]

Menke, A. Precision pharmacotherapy: Psychiatry’s future direction in preventing, diagnosing, and treating mental disorders. Pharm. Genomics Pers. Med., 2018, 11, 211-222.
[http://dx.doi.org/10.2147/PGPM.S146110] [PMID: 30510440]

Menke, A. Is the HPA axis as target for depression outdated, or is there a new hope? Front. Psychiatry, 2019, 10, 101.
[http://dx.doi.org/10.3389/fpsyt.2019.00101] [PMID: 30890970]

Mora, C.; Zonca, V.; Riva, M.A.; Cattaneo, A. Blood biomarkers and treatment response in major depression. Expert Rev. Mol. Diagn., 2018, 18(6), 513-529.
[http://dx.doi.org/10.1080/14737159.2018.1470927] [PMID: 29701114]

Kadriu, B.; Greenwald, M.; Henter, I.D.; Gilbert, J.R.; Kraus, C.; Park, L.T.; Zarate, C.A., Jr Ketamine and serotonergic psychedelics: Common mechanisms underlying the effects of rapid-acting antidepressants. Int. J. Neuropsychopharmacol., 2021, 24(1), 8-21.
[http://dx.doi.org/10.1093/ijnp/pyaa087] [PMID: 33252694]

Ionescu, D.F.; Fu, D.J.; Qiu, X.; Lane, R.; Lim, P.; Kasper, S.; Hough, D.; Drevets, W.C.; Manji, H.; Canuso, C.M. Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: Results of a Phase 3, double-blind, randomized study (ASPIRE II). Int. J. Neuropsychopharmacol., 2021, 24(1), 22-31.
[http://dx.doi.org/10.1093/ijnp/pyaa068] [PMID: 32861217]

Sullivan, P.F.; Neale, M.C.; Kendler, K.S. Genetic epidemiology of major depression: Review and meta-analysis. Am. J. Psychiatry, 2000, 157(10), 1552-1562.
[http://dx.doi.org/10.1176/appi.ajp.157.10.1552] [PMID: 11007705]

Klengel, T.; Binder, E.B. Epigenetics of stress-related psychiatric disorders and gene × environment interactions. Neuron, 2015, 86(6), 1343-1357.
[http://dx.doi.org/10.1016/j.neuron.2015.05.036] [PMID: 26087162]

Binder, EB Dissecting the molecular mechanisms of gene x environment interactions: Implications for diagnosis and treatment of stress-related psychiatric disorders. Eur. J. Psychotraumatol., 2017, 8(sup5), 1412745.
[http://dx.doi.org/10.1080/20008198.2017.1412745]

Menke, A.; Binder, E.B. Epigenetic alterations in depression and antidepressant treatment. Dialogues Clin. Neurosci., 2014, 16(3), 395-404.
[http://dx.doi.org/10.31887/DCNS.2014.16.3/amenke] [PMID: 25364288]

Heim, C.; Nemeroff, C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biol. Psychiatry, 2001, 49(12), 1023-1039.
[http://dx.doi.org/10.1016/S0006-3223(01)01157-X] [PMID: 11430844]

Hu, P.; Maita, I.; Phan, M.L.; Gu, E.; Kwok, C.; Dieterich, A.; Gergues, M.M.; Yohn, C.N.; Wang, Y.; Zhou, J.N.; Qi, X.R.; Swaab, D.F.; Pang, Z.P.; Lucassen, P.J.; Roepke, T.A.; Samuels, B.A. Early-life stress alters affective behaviors in adult mice through persistent activation of CRH-BDNF signaling in the oval bed nucleus of the stria terminalis. Transl. Psychiatry, 2020, 10(1), 396.
[http://dx.doi.org/10.1038/s41398-020-01070-3] [PMID: 33177511]

Zimmermann, P.; Brückl, T.; Nocon, A.; Pfister, H.; Binder, E.B.; Uhr, M.; Lieb, R.; Moffitt, T.E.; Caspi, A.; Holsboer, F.; Ising, M. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: Results from a 10-year prospective community study. Am. J. Psychiatry, 2011, 168(10), 1107-1116.
[http://dx.doi.org/10.1176/appi.ajp.2011.10111577] [PMID: 21865530]

Binder, E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology, 2009, 34(Suppl. 1), S186-S195.
[http://dx.doi.org/10.1016/j.psyneuen.2009.05.021] [PMID: 19560279]

McEwen, B.S. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol. Rev., 2007, 87(3), 873-904.
[http://dx.doi.org/10.1152/physrev.00041.2006] [PMID: 17615391]

Danese, A.J.; Lewis, S. Psychoneuroimmunology of early-life stress: The hidden wounds of childhood trauma? Neuropsychopharmacology, 2017, 42(1), 99-114.
[http://dx.doi.org/10.1038/npp.2016.198] [PMID: 27629365]

Kuhlman, K.R.; Chiang, J.J.; Horn, S.; Bower, J.E. Developmental psychoneuroendocrine and psychoneuroimmune pathways from childhood adversity to disease. Neurosci. Biobehav. Rev., 2017, 80, 166-184.
[http://dx.doi.org/10.1016/j.neubiorev.2017.05.020] [PMID: 28577879]

Kessler, R.C. The effects of stressful life events on depression. Annu. Rev. Psychol., 1997, 48(1), 191-214.
[http://dx.doi.org/10.1146/annurev.psych.48.1.191] [PMID: 9046559]

Menke, A.; Nitschke, F.; Hellmuth, A.; Helmel, J.; Wurst, C.; Stonawski, S.; Blickle, M.; Weiß, C.; Weber, H.; Hommers, L.; Domschke, K.; Deckert, J. Stress impairs response to antidepressants via HPA axis and immune system activation. Brain Behav. Immun., 2021, 93, 132-140.
[http://dx.doi.org/10.1016/j.bbi.2020.12.033] [PMID: 33422640]

Yang, J.Z.; Kang, C.Y.; Yuan, J.; Zhang, Y.; Wei, Y.J.; Xu, L.; Zhou, F.; Fan, X. Effect of adverse childhood experiences on hypothalamic–pituitary–adrenal (HPA) axis function and antidepressant efficacy in untreated first episode patients with major depressive disorder. Psychoneuroendocrinology, 2021, 134, 105432.
[http://dx.doi.org/10.1016/j.psyneuen.2021.105432] [PMID: 34607174]

Knorr, U.; Vinberg, M.; Kessing, L.V.; Wetterslev, J. Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysis. Psychoneuroendocrinology, 2010, 35(9), 1275-1286.
[http://dx.doi.org/10.1016/j.psyneuen.2010.04.001] [PMID: 20447770]

Stetler, C.; Miller, G.E. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosom. Med., 2011, 73(2), 114-126.
[http://dx.doi.org/10.1097/PSY.0b013e31820ad12b] [PMID: 21257974]

Holsboer, F. Stress, hypercortisolism and corticosteroid receptors in depression: Implicatons for therapy. J. Affect. Disord., 2001, 62(1-2), 77-91.
[http://dx.doi.org/10.1016/S0165-0327(00)00352-9] [PMID: 11172875]

Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 2000, 23(5), 477-501.
[http://dx.doi.org/10.1016/S0893-133X(00)00159-7] [PMID: 11027914]

Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 1981, 213(4514), 1394-1397.
[http://dx.doi.org/10.1126/science.6267699] [PMID: 6267699]

Schatzberg, A.F. Anna-Monika Award Lecture, DGPPN Kongress, 2013: The role of the hypothalamic–pituitary–adrenal (HPA) axis in the pathogenesis of psychotic major depression. World J. Biol. Psychiatry, 2015, 16(1), 2-11.
[http://dx.doi.org/10.3109/15622975.2014.916414] [PMID: 24933348]

Qi, X.R.; Kamphuis, W.; Wang, S.; Wang, Q.; Lucassen, P.J.; Zhou, J.N.; Swaab, D.F. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology, 2013, 38(6), 863-870.
[http://dx.doi.org/10.1016/j.psyneuen.2012.09.014] [PMID: 23137715]

Qi, C.C.; Zhang, Z.; Fang, H.; Liu, J.; Zhou, N.; Ge, J.F.; Chen, F.H.; Xiang, C.B.; Zhou, J.N. Antidepressant effects of abscisic acid mediated by the downregulation of corticotrophin-releasing hormone gene expression in rats. Int. J. Neuropsychopharmacol., 2014, 18(4), pyu006.
[PMID: 25552429]

Hu, P.; van Dam, A.M.; Wang, Y.; Lucassen, P.J.; Zhou, J.N. Retinoic acid and depressive disorders: Evidence and possible neurobiological mechanisms. Neurosci. Biobehav. Rev., 2020, 112, 376-391.
[http://dx.doi.org/10.1016/j.neubiorev.2020.02.013] [PMID: 32070693]

Rotondo, F.; Butz, H.; Syro, L.V.; Yousef, G.M.; Di Ieva, A.; Restrepo, L.M.; Quintanar-Stephano, A.; Berczi, I.; Kovacs, K. Arginine vasopressin (AVP): A review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system. Pituitary, 2016, 19(4), 345-355.
[http://dx.doi.org/10.1007/s11102-015-0703-0] [PMID: 26762848]

Pariante, C.M.; Miller, A.H. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biol. Psychiatry, 2001, 49(5), 391-404.
[http://dx.doi.org/10.1016/S0006-3223(00)01088-X] [PMID: 11274650]

Pariante, C.M. Glucocorticoid receptor function in vitro in patients with major depression. Stress, 2004, 7(4), 209-219.
[http://dx.doi.org/10.1080/10253890500069650] [PMID: 16019586]

Young, E.A.; Lopez, J.F.; Murphy-Weinberg, V.; Watson, S.J.; Akil, H. Mineralocorticoid receptor function in major depression. Arch. Gen. Psychiatry, 2003, 60(1), 24-28.
[http://dx.doi.org/10.1001/archpsyc.60.1.24] [PMID: 12511169]

McEwen, B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med., 1998, 338(3), 171-179.
[http://dx.doi.org/10.1056/NEJM199801153380307] [PMID: 9428819]

Leistner, C.; Menke, A. How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders. Psychoneuroendocrinology, 2018, 91, 235-260.
[http://dx.doi.org/10.1016/j.psyneuen.2018.01.023] [PMID: 29449045]

Carroll, B.J.; Martin, F.I.R.; Davies, B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. BMJ, 1968, 3(5613), 285-287.
[http://dx.doi.org/10.1136/bmj.3.5613.285] [PMID: 4385601]

Carroll, B.J.; Feinberg, M.; Greden, J.F.; Tarika, J.; Albala, A.A.; Haskett, R.F.; James, N.M.; Kronfol, Z.; Lohr, N.; Steiner, M.; de Vigne, J.P.; Young, E. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch. Gen. Psychiatry, 1981, 38(1), 15-22.
[http://dx.doi.org/10.1001/archpsyc.1981.01780260017001] [PMID: 7458567]

Nelson, J.C.; Davis, J.M. DST studies in psychotic depression: A meta-analysis. Am. J. Psychiatry, 1997, 154(11), 1497-1503.
[http://dx.doi.org/10.1176/ajp.154.11.1497] [PMID: 9356556]

Nierenberg, A.A.; Feinstein, A.R. How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. JAMA, 1988, 259(11), 1699-1702.
[http://dx.doi.org/10.1001/jama.1988.03720110061036] [PMID: 3278149]

Gervasoni, N.; Bertschy, G.; Osiek, C.; Perret, G.; Denis, R.; Golaz, J.; Rossier, M.F.; Bondolfi, G.; Aubry, J.M. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. J. Psychiatr. Res., 2004, 38(6), 553-557.
[http://dx.doi.org/10.1016/j.jpsychires.2004.04.008] [PMID: 15458850]

Carpenter, L.L.; Ross, N.S.; Tyrka, A.R.; Anderson, G.M.; Kelly, M.; Price, L.H. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology, 2009, 34(8), 1208-1213.
[http://dx.doi.org/10.1016/j.psyneuen.2009.03.009] [PMID: 19375869]

Holsboer, F.; Bender, W.; Benkert, O.; Klein, H.E.; Schmauss, M. Diagnostic value of dexamethasone suppression test in depression. Lancet, 1980, 316(8196), 706.
[http://dx.doi.org/10.1016/S0140-6736(80)92755-5] [PMID: 6106823]

Arana, G.W.; Baldessarini, R.J.; Ornsteen, M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch. Gen. Psychiatry, 1985, 42(12), 1193-1204.
[http://dx.doi.org/10.1001/archpsyc.1985.01790350067012] [PMID: 3000317]

Bardeleben, U.; Holsboer, F. Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J. Neuroendocrinol., 1989, 1(6), 485-488.
[http://dx.doi.org/10.1111/j.1365-2826.1989.tb00150.x] [PMID: 19210420]

Heuser, I.; Yassouridis, A.; Holsboer, F. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J. Psychiatr. Res., 1994, 28(4), 341-356.
[http://dx.doi.org/10.1016/0022-3956(94)90017-5] [PMID: 7877114]

Modell, S.; Yassouridis, A.; Huber, J.; Holsboer, F. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology, 1997, 65(3), 216-222.
[http://dx.doi.org/10.1159/000127275] [PMID: 9088003]

Kunugi, H.; Ida, I.; Owashi, T.; Kimura, M.; Inoue, Y.; Nakagawa, S.; Yabana, T.; Urushibara, T.; Kanai, R.; Aihara, M.; Yuuki, N.; Otsubo, T.; Oshima, A.; Kudo, K.; Inoue, T.; Kitaichi, Y.; Shirakawa, O.; Isogawa, K.; Nagayama, H.; Kamijima, K.; Nanko, S.; Kanba, S.; Higuchi, T.; Mikuni, M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: A multicenter study. Neuropsychopharmacology, 2006, 31(1), 212-220.
[http://dx.doi.org/10.1038/sj.npp.1300868] [PMID: 16123748]

Ising, M.; Horstmann, S.; Kloiber, S.; Lucae, S.; Binder, E.B.; Kern, N.; Künzel, H.E.; Pfennig, A.; Uhr, M.; Holsboer, F. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol. Psychiatry, 2007, 62(1), 47-54.
[http://dx.doi.org/10.1016/j.biopsych.2006.07.039] [PMID: 17123470]

Zobel, A.W.; Nickel, T.; Sonntag, A.; Uhr, M.; Holsboer, F.; Ising, M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. J. Psychiatr. Res., 2001, 35(2), 83-94.
[http://dx.doi.org/10.1016/S0022-3956(01)00013-9] [PMID: 11377437]

Appelhof, B.C.; Huyser, J.; Verweij, M.; Brouwer, J.P.; van Dyck, R.; Fliers, E.; Hoogendijk, W.J.G.; Tijssen, J.G.P.; Wiersinga, W.M.; Schene, A.H. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol. Psychiatry, 2006, 59(8), 696-701.
[http://dx.doi.org/10.1016/j.biopsych.2005.09.008] [PMID: 16368077]

Coryell, W.; Schlesser, M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry, 2001, 158(5), 748-753.
[http://dx.doi.org/10.1176/appi.ajp.158.5.748] [PMID: 11329397]

Hennings, J.M.; Ising, M.; Uhr, M.; Holsboer, F.; Lucae, S. Recurrent suicide attempts affect normalization of HPA axis dysregulation after recovery from major depression. Front. Psychiatry, 2022, 13, 937582.
[http://dx.doi.org/10.3389/fpsyt.2022.937582] [PMID: 36032226]

Menke, A.; Arloth, J.; Best, J.; Namendorf, C.; Gerlach, T.; Czamara, D.; Lucae, S.; Dunlop, B.W.; Crowe, T.M.; Garlow, S.J.; Nemeroff, C.B.; Ritchie, J.C.; Craighead, W.E.; Mayberg, H.S.; Rex-Haffner, M.; Binder, E.B.; Uhr, M. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests. Psychoneuroendocrinology, 2016, 69, 161-171.
[http://dx.doi.org/10.1016/j.psyneuen.2016.04.003] [PMID: 27107207]

Leistner, C.; Menke, A. Hypothalamic–pituitary–adrenal axis and stress. Handb. Clin. Neurol., 2020, 175, 55-64.
[http://dx.doi.org/10.1016/B978-0-444-64123-6.00004-7] [PMID: 33008543]

Menke, A.; Arloth, J.; Pütz, B.; Weber, P.; Klengel, T.; Mehta, D.; Gonik, M.; Rex-Haffner, M.; Rubel, J.; Uhr, M.; Lucae, S.; Deussing, J.M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E.B. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology, 2012, 37(6), 1455-1464.
[http://dx.doi.org/10.1038/npp.2011.331] [PMID: 22237309]

Menke, A.; Rex-Haffner, M.; Klengel, T.; Binder, E.B.; Mehta, D. Peripheral blood gene expression: It all boils down to the RNA collection tubes. BMC Res. Notes, 2012, 5(1), 1.
[http://dx.doi.org/10.1186/1756-0500-5-1] [PMID: 22214347]

Menke, A.; Arloth, J.; Gerber, M.; Rex-Haffner, M.; Uhr, M.; Holsboer, F.; Binder, E.B.; Holsboer-Trachsler, E.; Beck, J. Dexamethasone stimulated gene expression in peripheral blood indicates glucocorticoid-receptor hypersensitivity in job-related exhaustion. Psychoneuroendocrinology, 2014, 44, 35-46.
[http://dx.doi.org/10.1016/j.psyneuen.2014.02.013] [PMID: 24767618]

Menke, A.; Lehrieder, D.; Fietz, J.; Leistner, C.; Wurst, C.; Stonawski, S.; Reitz, J.; Lechner, K.; Busch, Y.; Weber, H.; Deckert, J.; Domschke, K. Childhood trauma dependent anxious depression sensitizes HPA axis function. Psychoneuroendocrinology, 2018, 98, 22-29.
[http://dx.doi.org/10.1016/j.psyneuen.2018.07.025] [PMID: 30086534]

Rampp, C.; Eichelkraut, A.; Best, J.; Czamara, D.; Rex-Haffner, M.; Uhr, M.; Binder, E.B.; Menke, A. Sex-related differential response to dexamethasone in endocrine and immune measures in depressed in-patients and healthy controls. J. Psychiatr. Res., 2018, 98, 107-115.
[http://dx.doi.org/10.1016/j.jpsychires.2017.12.020] [PMID: 29331929]

Arloth, J.; Bogdan, R.; Weber, P.; Frishman, G.; Menke, A.; Wagner, K.V.; Balsevich, G.; Schmidt, M.V.; Karbalai, N.; Czamara, D.; Altmann, A.; Trümbach, D.; Wurst, W.; Mehta, D.; Uhr, M.; Klengel, T.; Erhardt, A.; Carey, C.E.; Conley, E.D.; Ruepp, A.; Müller-Myhsok, B.; Hariri, A.R.; Binder, E.B.; Ripke, S.; Wray, N.R.; Lewis, C.M.; Hamilton, S.P.; Weissman, M.M.; Breen, G.; Byrne, E.M.; Blackwood, D.H.R.; Boomsma, D.I.; Cichon, S.; Heath, A.C.; Holsboer, F.; Lucae, S.; Madden, P.A.F.; Martin, N.G.; McGuffin, P.; Muglia, P.; Noethen, M.M.; Penninx, B.P.; Pergadia, M.L.; Potash, J.B.; Rietschel, M.; Lin, D.; Müller-Myhsok, B.; Shi, J.; Steinberg, S.; Grabe, H.J.; Lichtenstein, P.; Magnusson, P.; Perlis, R.H.; Preisig, M.; Smoller, J.W.; Stefansson, K.; Uher, R.; Kutalik, Z.; Tansey, K.E.; Teumer, A.; Viktorin, A.; Barnes, M.R.; Bettecken, T.; Binder, E.B.; Breuer, R.; Castro, V.M.; Churchill, S.E.; Coryell, W.H.; Craddock, N.; Craig, I.W.; Czamara, D.; De Geus, E.J.; Degenhardt, F.; Farmer, A.E.; Fava, M.; Frank, J.; Gainer, V.S.; Gallagher, P.J.; Gordon, S.D.; Goryachev, S.; Gross, M.; Guipponi, M.; Henders, A.K.; Herms, S.; Hickie, I.B.; Hoefels, S.; Hoogendijk, W.; Hottenga, J.J.; Iosifescu, D.V.; Ising, M.; Jones, I.; Jones, L.; Jung-Ying, T.; Knowles, J.A.; Kohane, I.S.; Kohli, M.A.; Korszun, A.; Landen, M.; Lawson, W.B.; Lewis, G.; MacIntyre, D.; Maier, W.; Mattheisen, M.; McGrath, P.J.; McIntosh, A.; McLean, A.; Middeldorp, C.M.; Middleton, L.; Montgomery, G.M.; Murphy, S.N.; Nauck, M.; Nolen, W.A.; Nyholt, D.R.; O’Donovan, M.; Oskarsson, H.; Pedersen, N.; Scheftner, W.A.; Schulz, A.; Schulze, T.G.; Shyn, S.I.; Sigurdsson, E.; Slager, S.L.; Smit, J.H.; Stefansson, H.; Steffens, M.; Thorgeirsson, T.; Tozzi, F.; Treutlein, J.; Uhr, M.; van den Oord, E.J.C.G.; Van Grootheest, G.; Völzke, H.; Weilburg, J.B.; Willemsen, G.; Zitman, F.G.; Neale, B.; Daly, M.; Levinson, D.F.; Sullivan, P.F. Genetic differences in the immediate transcriptome response to stress predict risk-related brain function and psychiatric disorders. Neuron, 2015, 86(5), 1189-1202.
[http://dx.doi.org/10.1016/j.neuron.2015.05.034] [PMID: 26050039]

Wiechmann, T.; Röh, S.; Sauer, S.; Czamara, D.; Arloth, J.; Ködel, M.; Beintner, M.; Knop, L.; Menke, A.; Binder, E.B.; Provençal, N. Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus. Clin. Epigenetics, 2019, 11(1), 83.
[http://dx.doi.org/10.1186/s13148-019-0682-5] [PMID: 31122292]

Smith, S.M.; Vale, W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci., 2006, 8(4), 383-395.
[http://dx.doi.org/10.31887/DCNS.2006.8.4/ssmith] [PMID: 17290797]

de Kloet, E.R.; Joëls, M.; Holsboer, F. Stress and the brain: From adaptation to disease. Nat. Rev. Neurosci., 2005, 6(6), 463-475.
[http://dx.doi.org/10.1038/nrn1683] [PMID: 15891777]

Schatzberg, A.F.; Keller, J.; Tennakoon, L.; Lembke, A.; Williams, G.; Kraemer, F.B.; Sarginson, J.E.; Lazzeroni, L.C.; Murphy, G.M. HPA axis genetic variation, cortisol and psychosis in major depression. Mol. Psychiatry, 2014, 19(2), 220-227.
[http://dx.doi.org/10.1038/mp.2013.129] [PMID: 24166410]

Keller, J.; Flores, B.; Gomez, R.G.; Solvason, H.B.; Kenna, H.; Williams, G.H.; Schatzberg, A.F. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry, 2006, 60(3), 275-281.
[http://dx.doi.org/10.1016/j.biopsych.2005.10.014] [PMID: 16458262]

Dwyer, J.B.; Aftab, A.; Radhakrishnan, R.; Widge, A.; Rodriguez, C.I.; Carpenter, L.L.; Nemeroff, C.B.; McDonald, W.M.; Kalin, N.H. Hormonal treatments for major depressive disorder: State of the art. Am. J. Psychiatry, 2020, 177(8), 686-705.
[http://dx.doi.org/10.1176/appi.ajp.2020.19080848] [PMID: 32456504]

Ding, Y.; Wei, Z.; Yan, H.; Guo, W. Efficacy of treatments targeting hypothalamic-pituitary-adrenal systems for major depressive disorder: A meta-analysis. Front. Pharmacol., 2021, 12, 732157.
[http://dx.doi.org/10.3389/fphar.2021.732157] [PMID: 34566653]

Aguilera, G.; Rabadan-Diehl, C. Vasopressinergic regulation of the hypothalamic–pituitary–adrenal axis: Implications for stress adaptation. Regul. Pept., 2000, 96(1-2), 23-29.
[http://dx.doi.org/10.1016/S0167-0115(00)00196-8] [PMID: 11102648]

Peter, J.; Burbach, H.; Adan, R.A.H.; Lolait, S.J.; van Leeuwen, F.W.; Mezey, E.; Palkovits, M.; Barberis, C. Molecular neurobiology and pharmacology of the Vasopressin/Oxytocin receptor family. Cell. Mol. Neurobiol., 1995, 15(5), 573-595.
[http://dx.doi.org/10.1007/BF02071318] [PMID: 8719042]

Rabadan-Diehl, C.; Lolait, S.J.; Aguilera, G. Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat. J. Neuroendocrinol., 1995, 7(12), 903-910.
[http://dx.doi.org/10.1111/j.1365-2826.1995.tb00734.x] [PMID: 8745267]

Meynen, G.; Unmehopa, U.A.; van Heerikhuize, J.J.; Hofman, M.A.; Swaab, D.F.; Hoogendijk, W.J.G. Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report. Biol. Psychiatry, 2006, 60(8), 892-895.
[http://dx.doi.org/10.1016/j.biopsych.2005.12.010] [PMID: 16499879]

Holsboer, F.; Ising, M. Hypothalamic stress systems in mood disorders. Handb. Clin. Neurol., 2021, 182, 33-48.
[http://dx.doi.org/10.1016/B978-0-12-819973-2.00003-4] [PMID: 34266603]

Chaki, S. Vasopressin V1B receptor antagonists as potential antidepressants. Int. J. Neuropsychopharmacol., 2021, 24(6), 450-463.
[http://dx.doi.org/10.1093/ijnp/pyab013] [PMID: 33733667]

Griebel, G.; Beeské, S.; Stahl, S.M. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: Results from 4 randomized, double-blind, placebo-controlled studies. J. Clin. Psychiatry, 2012, 73(11), 1403-1411.
[http://dx.doi.org/10.4088/JCP.12m07804] [PMID: 23146246]

Katz, D.A.; Locke, C.; Greco, N.; Liu, W.; Tracy, K.A. Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial. Brain Behav., 2017, 7(3), e00628.
[http://dx.doi.org/10.1002/brb3.628] [PMID: 28293470]

Kamiya, M.; Sabia, H.D.; Marella, J.; Fava, M.; Nemeroff, C.B.; Umeuchi, H.; Iijima, M.; Chaki, S.; Nishino, I. Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study. J. Psychiatr. Res., 2020, 128, 43-51.
[http://dx.doi.org/10.1016/j.jpsychires.2020.05.017] [PMID: 32521250]

Watson, S.; Gallagher, P.; Porter, R.J.; Smith, M.S.; Herron, L.J.; Bulmer, S.; Young, A.H.; Ferrier, I.N. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol. Psychiatry, 2012, 72(11), 943-949.
[http://dx.doi.org/10.1016/j.biopsych.2012.05.029] [PMID: 22770649]

Belanoff, J.K.; Flores, B.H.; Kalezhan, M.; Sund, B.; Schatzberg, A.F. Rapid reversal of psychotic depression using mifepristone. J. Clin. Psychopharmacol., 2001, 21(5), 516-521.
[http://dx.doi.org/10.1097/00004714-200110000-00009] [PMID: 11593077]

Flores, B.H.; Kenna, H.; Keller, J.; Solvason, H.B.; Schatzberg, A.F. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology, 2006, 31(3), 628-636.
[http://dx.doi.org/10.1038/sj.npp.1300884] [PMID: 16160710]

DeBattista, C.; Belanoff, J.; Glass, S.; Khan, A.; Horne, R.L.; Blasey, C.; Carpenter, L.L.; Alva, G. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol. Psychiatry, 2006, 60(12), 1343-1349.
[http://dx.doi.org/10.1016/j.biopsych.2006.05.034] [PMID: 16889757]

Belanoff, J.K.; Rothschild, A.J.; Cassidy, F.; DeBattista, C.; Baulieu, E.E.; Schold, C.; Schatzberg, A.F. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol. Psychiatry, 2002, 52(5), 386-392.
[http://dx.doi.org/10.1016/S0006-3223(02)01432-4] [PMID: 12242054]

Simpson, G.M.; Sheshai, A.E.; Loza, N.; Kingsbury, S.J.; Fayek, M.; Rady, A.; Fawzy, W. An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. J. Clin. Psychiatry, 2005, 66(5), 598-602.
[http://dx.doi.org/10.4088/JCP.v66n0509] [PMID: 15889946]

Blasey, C.M.; DeBattista, C.; Roe, R.; Block, T.; Belanoff, J.K. A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction. Contemp. Clin. Trials, 2009, 30(4), 284-288.
[http://dx.doi.org/10.1016/j.cct.2009.03.001] [PMID: 19318138]

Block, T.S.; Kushner, H.; Kalin, N.; Nelson, C.; Belanoff, J.; Schatzberg, A. Combined analysis of mifepristone for psychotic depression: Plasma levels associated with clinical response. Biol. Psychiatry, 2018, 84(1), 46-54.
[http://dx.doi.org/10.1016/j.biopsych.2018.01.008] [PMID: 29523415]

Holsboer, F. CRHR1 antagonists as novel treatment strategies. CNS Spectr., 2001, 6(7), 590-594.
[http://dx.doi.org/10.1017/S1092852900002133] [PMID: 15573022]

Zhou, J.N.; Fang, H. Transcriptional regulation of corticotropin-releasing hormone gene in stress response. IBRO Rep., 2018, 5, 137-146.
[http://dx.doi.org/10.1016/j.ibror.2018.08.003] [PMID: 30591954]

Holsboer, F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res., 1999, 33(3), 181-214.
[http://dx.doi.org/10.1016/S0022-3956(98)90056-5] [PMID: 10367986]

Owens, M.J.; Nemeroff, C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev., 1991, 43(4), 425-473.
[PMID: 1775506]

Zobel, A.W.; Nickel, T.; Künzel, H.E.; Ackl, N.; Sonntag, A.; Ising, M.; Holsboer, F. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J. Psychiatr. Res., 2000, 34(3), 171-181.
[http://dx.doi.org/10.1016/S0022-3956(00)00016-9] [PMID: 10867111]

Binneman, B.; Feltner, D.; Kolluri, S.; Shi, Y.; Qiu, R.; Stiger, T. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH₁ antagonist) in the treatment of major depression. Am. J. Psychiatry, 2008, 165(5), 617-620.
[http://dx.doi.org/10.1176/appi.ajp.2008.07071199] [PMID: 18413705]

Spierling, S.R.; Zorrilla, E.P. Don’t stress about CRF: Assessing the translational failures of CRF1antagonists. Psychopharmacology, 2017, 234(9-10), 1467-1481.
[http://dx.doi.org/10.1007/s00213-017-4556-2] [PMID: 28265716]

Schwandt, M.L.; Cortes, C.R.; Kwako, L.E.; George, D.T.; Momenan, R.; Sinha, R.; Grigoriadis, D.E.; Pich, E.M.; Leggio, L.; Heilig, M. The CRF1 antagonist verucerfont in anxious alcohol-dependent women: Translation of neuroendocrine, but not of anti-craving effects. Neuropsychopharmacology, 2016, 41(12), 2818-2829.
[http://dx.doi.org/10.1038/npp.2016.61] [PMID: 27109623]

Dunlop, B.W.; Rothbaum, B.O.; Binder, E.B.; Duncan, E.; Harvey, P.D.; Jovanovic, T.; Kelley, M.E.; Kinkead, B.; Kutner, M.; Iosifescu, D.V.; Mathew, S.J.; Neylan, T.C.; Kilts, C.D.; Nemeroff, C.B.; Mayberg, H.S. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Trials, 2014, 15(1), 240.
[http://dx.doi.org/10.1186/1745-6215-15-240] [PMID: 24950747]

Dunlop, B.W.; Binder, E.B.; Iosifescu, D.; Mathew, S.J.; Neylan, T.C.; Pape, J.C.; Carrillo-Roa, T.; Green, C.; Kinkead, B.; Grigoriadis, D.; Rothbaum, B.O.; Nemeroff, C.B.; Mayberg, H.S. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol. Psychiatry, 2017, 82(12), 866-874.
[http://dx.doi.org/10.1016/j.biopsych.2017.06.024] [PMID: 28793974]

Binder, E.B.; Salyakina, D.; Lichtner, P.; Wochnik, G.M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M.A.; Nickel, T.; Künzel, H.E.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J.C.; Lõhmussaar, E.; Strom, T.M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Muller-Myhsok, B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet., 2004, 36(12), 1319-1325.
[http://dx.doi.org/10.1038/ng1479] [PMID: 15565110]

Matosin, N.; Halldorsdottir, T.; Binder, E.B. Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: The FKBP5 Model. Biol. Psychiatry, 2018, 83(10), 821-830.
[http://dx.doi.org/10.1016/j.biopsych.2018.01.021] [PMID: 29573791]

Martins, J.; Yusupov, N.; Binder, E.B.; Brückl, T.M.; Czamara, D. Early adversity as the prototype gene × environment interaction in mental disorders? Pharmacol. Biochem. Behav., 2022, 215, 173371.
[http://dx.doi.org/10.1016/j.pbb.2022.173371] [PMID: 35271857]

Klengel, T.; Mehta, D.; Anacker, C.; Rex-Haffner, M.; Pruessner, J.C.; Pariante, C.M.; Pace, T.W.W.; Mercer, K.B.; Mayberg, H.S.; Bradley, B.; Nemeroff, C.B.; Holsboer, F.; Heim, C.M.; Ressler, K.J.; Rein, T.; Binder, E.B. Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions. Nat. Neurosci., 2013, 16(1), 33-41.
[http://dx.doi.org/10.1038/nn.3275] [PMID: 23201972]

Tatro, E.T.; Everall, I.P.; Masliah, E.; Hult, B.J.; Lucero, G.; Chana, G.; Soontornniyomkij, V.; Achim, C.L. Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder. J. Neuroimmune Pharmacol., 2009, 4(2), 218-226.
[http://dx.doi.org/10.1007/s11481-009-9146-6] [PMID: 19199039]

Chen, H.; Wang, N.; Zhao, X.; Ross, C.A.; O’Shea, K.S.; McInnis, M.G. Gene expression alterations in bipolar disorder postmortem brains. Bipolar Disord., 2013, 15(2), 177-187.
[http://dx.doi.org/10.1111/bdi.12039] [PMID: 23360497]

Sinclair, D.; Fillman, S.G.; Webster, M.J.; Weickert, C.S. Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness. Sci. Rep., 2013, 3(1), 3539.
[http://dx.doi.org/10.1038/srep03539] [PMID: 24345775]

Young, K.A.; Thompson, P.M.; Cruz, D.A.; Williamson, D.E.; Selemon, L.D. BA11 FKBP5 expression levels correlate with dendritic spine density in postmortem PTSD and controls. Neurobiol. Stress, 2015, 2, 67-72.
[http://dx.doi.org/10.1016/j.ynstr.2015.07.002] [PMID: 26844242]

Hawn, S.E.; Sheerin, C.M.; Lind, M.J.; Hicks, T.A.; Marraccini, M.E.; Bountress, K.; Bacanu, S.A.; Nugent, N.R.; Amstadter, A.B. GxE effects of FKBP5 and traumatic life events on PTSD: A meta-analysis. J. Affect. Disord., 2019, 243, 455-462.
[http://dx.doi.org/10.1016/j.jad.2018.09.058] [PMID: 30273884]

Kim, H.J.; Jin, H.J. Polymorphisms in the FKBP5 gene are associated with attention deficit and hyperactivity disorder in Korean children. Behav. Brain Res., 2021, 414, 113508.
[http://dx.doi.org/10.1016/j.bbr.2021.113508] [PMID: 34352291]

Lobo, J.J.; Ayoub, L.J.; Moayedi, M.; Linnstaedt, S.D. Hippocampal volume, FKBP5 genetic risk alleles, and childhood trauma interact to increase vulnerability to chronic multisite musculoskeletal pain. Sci. Rep., 2022, 12(1), 6511.
[http://dx.doi.org/10.1038/s41598-022-10411-9] [PMID: 35444168]

Bortsov, A.V.; Smith, J.E.; Diatchenko, L.; Soward, A.C.; Ulirsch, J.C.; Rossi, C.; Swor, R.A.; Hauda, W.E.; Peak, D.A.; Jones, J.S.; Holbrook, D.; Rathlev, N.K.; Foley, K.A.; Lee, D.C.; Collette, R.; Domeier, R.M.; Hendry, P.L.; McLean, S.A. Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure. Pain, 2013, 154(8), 1419-1426.
[http://dx.doi.org/10.1016/j.pain.2013.04.037] [PMID: 23707272]

Strączkowski, M.; Stefanowicz, M.; Matulewicz, N.; Nikołajuk, A.; Karczewska-Kupczewska, M. Relation of adipose tissue and skeletal muscle FKBP5 expression with insulin sensitivity and the regulation of FKBP5 by insulin and free fatty acids. Endocrine, 2022, 76(3), 536-542.
[http://dx.doi.org/10.1007/s12020-022-03018-7] [PMID: 35212883]

Smedlund, K.B.; Sanchez, E.R.; Hinds, T.D., Jr FKBP51 and the molecular chaperoning of metabolism. Trends Endocrinol. Metab., 2021, 32(11), 862-874.
[http://dx.doi.org/10.1016/j.tem.2021.08.003] [PMID: 34481731]

Ising, M.; Maccarrone, G.; Brückl, T.; Scheuer, S.; Hennings, J.; Holsboer, F.; Turck, C.; Uhr, M.; Lucae, S. FKBP5 gene expression predicts antidepressant treatment outcome in depression. Int. J. Mol. Sci., 2019, 20(3), 485.
[http://dx.doi.org/10.3390/ijms20030485] [PMID: 30678080]

Schmidt, M.V.; Paez-Pereda, M.; Holsboer, F.; Hausch, F. The prospect of FKBP51 as a drug target. ChemMedChem, 2012, 7(8), 1351-1359.
[http://dx.doi.org/10.1002/cmdc.201200137] [PMID: 22581765]

Gaali, S.; Gopalakrishnan, R.; Wang, Y.; Kozany, C.; Hausch, F. The chemical biology of immunophilin ligands. Curr. Med. Chem., 2011, 18(35), 5355-5379.
[http://dx.doi.org/10.2174/092986711798194342] [PMID: 22087830]

Blackburn, E.A.; Walkinshaw, M.D. Targeting FKBP isoforms with small-molecule ligands. Curr. Opin. Pharmacol., 2011, 11(4), 365-371.
[http://dx.doi.org/10.1016/j.coph.2011.04.007] [PMID: 21803654]

Kolos, J.M.; Voll, A.M.; Bauder, M.; Hausch, F. FKBP Ligands—Where We Are and Where to Go? Front. Pharmacol., 2018, 9, 1425.
[http://dx.doi.org/10.3389/fphar.2018.01425] [PMID: 30568592]

Gaali, S.; Kirschner, A.; Cuboni, S.; Hartmann, J.; Kozany, C.; Balsevich, G.; Namendorf, C.; Fernandez-Vizarra, P.; Sippel, C.; Zannas, A.S.; Draenert, R.; Binder, E.B.; Almeida, O.F.X.; Rühter, G.; Uhr, M.; Schmidt, M.V.; Touma, C.; Bracher, A.; Hausch, F. Selective inhibitors of the FK506-binding protein 51 by induced fit. Nat. Chem. Biol., 2015, 11(1), 33-37.
[http://dx.doi.org/10.1038/nchembio.1699] [PMID: 25436518]

Balsevich, G.; Häusl, A.S.; Meyer, C.W.; Karamihalev, S.; Feng, X.; Pöhlmann, M.L.; Dournes, C.; Uribe-Marino, A.; Santarelli, S.; Labermaier, C.; Hafner, K.; Mao, T.; Breitsamer, M.; Theodoropoulou, M.; Namendorf, C.; Uhr, M.; Paez-Pereda, M.; Winter, G.; Hausch, F.; Chen, A.; Tschöp, M.H.; Rein, T.; Gassen, N.C.; Schmidt, M.V. Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function. Nat. Commun., 2017, 8(1), 1725.
[http://dx.doi.org/10.1038/s41467-017-01783-y] [PMID: 29170369]

Bauder, M.; Meyners, C.; Purder, P.L.; Merz, S.; Sugiarto, W.O.; Voll, A.M.; Heymann, T.; Hausch, F. Structure-based design of high-affinity macrocyclic FKBP51 inhibitors. J. Med. Chem., 2021, 64(6), 3320-3349.
[http://dx.doi.org/10.1021/acs.jmedchem.0c02195] [PMID: 33666419]

Hartmann, J.; Bajaj, T.; Klengel, C.; Chatzinakos, C.; Ebert, T.; Dedic, N.; McCullough, K.M.; Lardenoije, R.; Joëls, M.; Meijer, O.C.; McCann, K.E.; Dudek, S.M.; Sarabdjitsingh, R.A.; Daskalakis, N.P.; Klengel, T.; Gassen, N.C.; Schmidt, M.V.; Ressler, K.J. Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5. Cell Rep., 2021, 35(9), 109185.
[http://dx.doi.org/10.1016/j.celrep.2021.109185] [PMID: 34077736]

Zhao, J.; Verwer, R.W.H.; Gao, S.F.; Qi, X.R.; Lucassen, P.J.; Kessels, H.W.; Swaab, D.F. Prefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide. J. Psychiatr. Res., 2018, 102, 261-274.
[http://dx.doi.org/10.1016/j.jpsychires.2018.04.020] [PMID: 29753198]

Wu, X.; Balesar, R.; Lu, J.; Farajnia, S.; Zhu, Q.; Huang, M.; Bao, A.M.; Swaab, D.F. Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression. Brain Struct. Funct., 2017, 222(9), 4079-4088.
[http://dx.doi.org/10.1007/s00429-017-1442-y] [PMID: 28608287]

Hashimoto, K. Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective. Psychiatry Clin. Neurosci., 2019, 73(10), 613-627.
[http://dx.doi.org/10.1111/pcn.12902] [PMID: 31215725]

Fukumoto, K.; Toki, H.; Iijima, M.; Hashihayata, T.; Yamaguchi, J.; Hashimoto, K.; Chaki, S. Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-. Ketamine. J. Pharmacol. Exp. Ther., 2017, 361(1), 9-16.
[http://dx.doi.org/10.1124/jpet.116.239228] [PMID: 28115553]

Zanos, P.; Moaddel, R.; Morris, P.J.; Georgiou, P.; Fischell, J.; Elmer, G.I.; Alkondon, M.; Yuan, P.; Pribut, H.J.; Singh, N.S.; Dossou, K.S.S.; Fang, Y.; Huang, X.P.; Mayo, C.L.; Wainer, I.W.; Albuquerque, E.X.; Thompson, S.M.; Thomas, C.J.; Zarate, C.A., Jr; Gould, T.D. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature, 2016, 533(7604), 481-486.
[http://dx.doi.org/10.1038/nature17998] [PMID: 27144355]

Anderzhanova, E.; Hafner, K.; Genewsky, A.J.; Soliman, A.; Pöhlmann, M.L.; Schmidt, M.V.; Blum, R.; Wotjak, C.T.; Gassen, N.C. The stress susceptibility factor FKBP51 controls S-ketamine-evoked release of mBDNF in the prefrontal cortex of mice. Neurobiol. Stress, 2020, 13, 100239.
[http://dx.doi.org/10.1016/j.ynstr.2020.100239] [PMID: 33344695]

Gassen, N.C.; Hartmann, J.; Zannas, A.S.; Kretzschmar, A.; Zschocke, J.; Maccarrone, G.; Hafner, K.; Zellner, A.; Kollmannsberger, L.K.; Wagner, K.V.; Mehta, D.; Kloiber, S.; Turck, C.W.; Lucae, S.; Chrousos, G.P.; Holsboer, F.; Binder, E.B.; Ising, M.; Schmidt, M.V.; Rein, T. FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications. Mol. Psychiatry, 2016, 21(2), 277-289.
[http://dx.doi.org/10.1038/mp.2015.38] [PMID: 25849320]

Cattaneo, A.; Riva, M.A. STRESS-induced mechanisms in mental illness: A role for glucocorticoid signalling. J. Steroid Biochem. Mol. Biol., 2016, 160, 169-174.
[PMID: 26241031]

Cattaneo, A.; Macchi, F.; Plazzotta, G.; Veronica, B.; Bocchio-Chiavetto, L.; Riva, M.A.; Pariante, C.M. Inflammation and neuronal plasticity: A link between childhood trauma and depression pathogenesis. Front. Cell. Neurosci., 2015, 9, 40.
[http://dx.doi.org/10.3389/fncel.2015.00040] [PMID: 25873859]

Ficek, J.; Zygmunt, M.; Piechota, M.; Hoinkis, D.; Rodriguez Parkitna, J.; Przewlocki, R.; Korostynski, M. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action. BMC Genomics, 2016, 17(1), 362.
[http://dx.doi.org/10.1186/s12864-016-2713-3] [PMID: 27188165]